- Home
- PLSE vs TFIN Comparison
PLSE vs TFIN Comparison
Compare PLSE & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLSE
- TFIN
- Stock Information
- Founded
- PLSE 2014
- TFIN 1981
- Country
- PLSE United States
- TFIN United States
- Employees
- PLSE N/A
- TFIN N/A
- Industry
- PLSE Medical/Dental Instruments
- TFIN Major Banks
- Sector
- PLSE Health Care
- TFIN Finance
- Exchange
- PLSE Nasdaq
- TFIN Nasdaq
- Market Cap
- PLSE 1.1B
- TFIN 1.3B
- IPO Year
- PLSE 2016
- TFIN N/A
- Fundamental
- Price
- PLSE $16.03
- TFIN $65.27
- Analyst Decision
- PLSE Buy
- TFIN Hold
- Analyst Count
- PLSE 1
- TFIN 6
- Target Price
- PLSE $22.00
- TFIN $68.50
- AVG Volume (30 Days)
- PLSE 197.4K
- TFIN 248.6K
- Earning Date
- PLSE 08-11-2025
- TFIN 07-16-2025
- Dividend Yield
- PLSE N/A
- TFIN N/A
- EPS Growth
- PLSE N/A
- TFIN N/A
- EPS
- PLSE N/A
- TFIN 0.37
- Revenue
- PLSE N/A
- TFIN $401,390,000.00
- Revenue This Year
- PLSE N/A
- TFIN $12.09
- Revenue Next Year
- PLSE N/A
- TFIN $14.37
- P/E Ratio
- PLSE N/A
- TFIN $176.95
- Revenue Growth
- PLSE N/A
- TFIN 0.68
- 52 Week Low
- PLSE $13.50
- TFIN $42.90
- 52 Week High
- PLSE $25.00
- TFIN $110.58
- Technical
- Relative Strength Index (RSI)
- PLSE 50.73
- TFIN 66.79
- Support Level
- PLSE $15.19
- TFIN $63.62
- Resistance Level
- PLSE $17.27
- TFIN $67.26
- Average True Range (ATR)
- PLSE 0.78
- TFIN 2.30
- MACD
- PLSE 0.20
- TFIN 0.87
- Stochastic Oscillator
- PLSE 52.76
- TFIN 86.03
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.